GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Institutional Ownership

PolyPeptide Group AG (XSWX:PPGN) Institutional Ownership : 18.72% (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PolyPeptide Group AG's institutional ownership is 18.72%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PolyPeptide Group AG's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PolyPeptide Group AG's Float Percentage Of Total Shares Outstanding is 0.00%.


PolyPeptide Group AG Institutional Ownership Historical Data

The historical data trend for PolyPeptide Group AG's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Institutional Ownership Chart

PolyPeptide Group AG Historical Data

The historical data trend for PolyPeptide Group AG can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 23.46 21.19 19.99 19.71 18.97 18.72 18.66 19.14 18.84 18.72

PolyPeptide Group AG Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


PolyPeptide Group AG (XSWX:PPGN) Business Description

Traded in Other Exchanges
Address
Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines